WILLIAM G WIERDA to Clinical Studies as Topic
This is a "connection" page, showing publications WILLIAM G WIERDA has written about Clinical Studies as Topic.
Connection Strength
0.052
-
Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia. Blood Cancer J. 2022 05 20; 12(5):80.
Score: 0.052
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.